DK146801B - PROCEDURE FOR SEPARATING D-P-HYDROXYPHENYLGYLINE FROM A MIXTURE OF D- AND DL-P-HYDROXYPHENYLGYLIN OR ITS ALKYL ESTERS OR MIXTURES THEREOF - Google Patents

PROCEDURE FOR SEPARATING D-P-HYDROXYPHENYLGYLINE FROM A MIXTURE OF D- AND DL-P-HYDROXYPHENYLGYLIN OR ITS ALKYL ESTERS OR MIXTURES THEREOF Download PDF

Info

Publication number
DK146801B
DK146801B DK594175AA DK594175A DK146801B DK 146801 B DK146801 B DK 146801B DK 594175A A DK594175A A DK 594175AA DK 594175 A DK594175 A DK 594175A DK 146801 B DK146801 B DK 146801B
Authority
DK
Denmark
Prior art keywords
hydroxyphenylglycine
mixture
alkyl esters
mixtures
separating
Prior art date
Application number
DK594175AA
Other languages
Danish (da)
Other versions
DK594175A (en
DK146801C (en
Inventor
Shyam Kirti Gupta
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK594175A publication Critical patent/DK594175A/en
Publication of DK146801B publication Critical patent/DK146801B/en
Application granted granted Critical
Publication of DK146801C publication Critical patent/DK146801C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00Separation of optically-active compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Description

i 146801in 146801

Opfindelsen angår en fremgangsmåde til adskillelse af D-p-hydroxyphenylglycin fra en blanding indeholdende D- og DL-p-hydroxyphenylglycin eller deres alkylestere med 1-10 car-bonatomer i alkyldelen eller blandinger deraf.The invention relates to a process for separating D-p-hydroxyphenylglycine from a mixture containing D- and DL-p-hydroxyphenylglycine or their alkyl esters with 1-10 carbon atoms in the alkyl moiety or mixtures thereof.

5 D-p-hydroxyphenylglycin er et velkendt produkt, som anvendes ved syntesen af vigtige β-lactam-antibiotica, såsom [β~β-(Ώ- 2-amino-2-p-hydroxyphenyl)-acétamido] penicillinD-p-hydroxyphenylglycine is a well-known product used in the synthesis of important β-lactam antibiotics such as [β ~ β- (Ώ-2-amino-2-p-hydroxyphenyl) -acetamido] penicillin

Amoxycillinamoxycillin

Fremstillingen af optisk homogent D-p-hydroxyphenylglycin er tidligere blevet udført ved procedurer, som indebærer adskil-10 lelse af DL-p-hydroxyphenylglycin eller derivater deraf som beskrevet f.eks. i 'beskrivelserne til belgisk patent nr.The preparation of optically homogeneous D-p-hydroxyphenylglycine has previously been carried out by procedures involving the separation of DL-p-hydroxyphenylglycine or derivatives thereof as described e.g. in the descriptions of Belgian patent no.

795 874 og nederlandsk patentansøgning nr. 7 311 012.795 874 and Dutch Patent Application No. 7 311 012.

Den foreliggende opfindelse- angår en fremgangsmåde til ad-15 skillelse af D-p-hydroxyphenylglycin fra en blanding indehol dende D- og DL-p-hydroxyphenylglycin og/eller alkylestere deraf. Princippet er baseret på den hidtil ukendte og overra-skende kendsgerning, at hydrogenbromidsaltet af DL-p-hydroxyphenylglycin er mindre opløseligt i vandig hydrogenbromid-20 syre end hydrogenbromidsaltet af D-p-hydroxyphenylglycin. Der har ikke kunnet findes nogen opløselighedsforskelle for de tilsvarende salte med saltsyre eller svovlsyre.The present invention relates to a process for separating D-p-hydroxyphenylglycine from a mixture containing D- and DL-p-hydroxyphenylglycine and / or alkyl esters thereof. The principle is based on the novel and surprising fact that the hydrogen bromide salt of DL-p-hydroxyphenylglycine is less soluble in aqueous hydrogen bromide acid than the hydrogen bromide salt of D-p-hydroxyphenylglycine. No solubility differences were found for the corresponding salts with hydrochloric acid or sulfuric acid.

I overensstemmelse hermed er fremgangsmåden ifølge opfindelsen ejendommelig ved det i kravets kendetegnende del anførte.Accordingly, the process of the invention is peculiar to the characterizing part of the claim.

2 146801 Når en "blanding af D- og DL-p-hydroxyphenylglycin omrøres i vandig hydrogenbromidsyre, dannes hydrogenbromidsaltet af DL-p-hydroxyphenylglycin, som derpå udkrystalliserer ved afkøling. Hydrogenbromidsaltet af D-p-hydroxyphenylglycin dannes samti-5 digt, men forbliver i opløsning. En simpel filtrering ved dette tidspunkt resulterer i adskillelsen af de ovennævnte to produkter. Når den fraskilte opløsning indstilles til pH 4-6, fortrinsvis 5j5-5>7, som er D-p-hydroxyphenylglycins isoelektriske punkt, udkrystalliserer D-p-hydroxyphenylglycin fra opløsningen ]_q som den frie aminosyre.When a mixture of D- and DL-β-hydroxyphenylglycine is stirred in aqueous hydrobromic acid, the hydrogen bromide salt is formed by DL-β-hydroxyphenylglycine, which then crystallizes upon cooling. The hydrogen bromide salt of D A simple filtration at this point results in the separation of the above two products. such as the free amino acid.

Når der ved fremgangsmåden ifølge opfindelsen anvendes alkyl-esterne af D- og DL-p-hydroxyphenylglycin, fører denne fremgangsmåde til samtidig hydrolyse af esterne og optisk adskillelse af resulterende D-p-hydroxyphenylglycin-hydrobromid fra 15 DL-p-hydroxyphenylglycin-hydrobromid i en arbejdsgang uden isolering af mellemprodukter.When used in the process of the invention, the alkyl esters of D- and DL-β-hydroxyphenylglycine, this process results in simultaneous hydrolysis of the esters and optical separation of the resulting Dβ-hydroxyphenylglycine hydrobromide from DL-β-hydroxyphenylglycine hydrobromide in one operation. without isolation of intermediates.

En blanding indeholdende varierende mængder D- og DL-p-hydroxyphenylglycin sættes til en kommercielt tilgængelig 48 % vandig opløsning af hydrogenbromidsyre og opvarmes indtil der fås en 20 opløsning. De anvendte mængder hydrogenbromidsyreopløsning og varme er ikke kritiske, men skal netop være tilstrækkelige til at frembringe opløsning af den tilsatte p-h.ydrox.yphenylglycin-blanding. Hydrogenbromidsyreopløsningen anvendes i støkiometrisk overskud, sædvanligvis i et molforhold mellem HBr og 25 p-hydroxyphenylglycin på fra 2:1 til 4:1. Større volumener hydrogenbromidsyreopløsning kan på uønsket måde forøge opløseligheden af DL-p-hydroxyphenylglycin-hydrobromid. Den tilførte mængde varme varierer med det anvendte volumen hydrogenbromidsyreopløsning og den tilsatte mængde p-hydroxyphenylglycin-blan-30 ding. Temperaturer på 100-115°C er sædvanligvis tilstrækkelige til at bringe det tilsatte materiale hurtigt i opløsning.A mixture containing varying amounts of D- and DL-β-hydroxyphenylglycine is added to a commercially available 48% aqueous solution of hydrobromic acid and heated until a solution is obtained. The amounts of hydrogen bromic acid solution and heat used are not critical, but must be sufficient to produce dissolution of the added p-hydroxyphenylglycine mixture. The hydrobromic acid solution is used in stoichiometric excess, usually in a molar ratio of HBr to 25 p-hydroxyphenylglycine of from 2: 1 to 4: 1. Larger volumes of hydrogen bromic acid solution may undesirably increase the solubility of DL-β-hydroxyphenylglycine hydrobromide. The amount of heat supplied varies with the volume of hydrogen bromide acid solution used and the amount of p-hydroxyphenylglycine mixture added. Temperatures of 100-115 ° C are usually sufficient to rapidly dissolve the added material.

Det krystallinske produkt, som udskilles ved afkøling til stuetemperatur (20-25°C) fjernes ved filtrering eller centrifugering. Det består hovedsageligt af DL-p-hydroxyphenylglycin-35 hydrobromid som bedømt ved optisk drejning. Den fraskilte op- 3 146801 løsning, indeholdende hydrobromidsaltet af D-p-hydroxyphenyl-glycin, indstilles med alkali, fortrinsvis ammoniakvand, til pH 4-6, fortrinsvis 5,5-5,7. Den krystallinske frie aminosyre, som dannes således eller opnås ved koncentrering, fraskilles 5 ved filtrering eller centrifugering. Det således opnåede D-p- hydroxyphenylglycin er af ca. 99 % renhed som bestemt ved optisk drejning og tyndtlagschromatografisk undersøgelse.The crystalline product which is separated by cooling to room temperature (20-25 ° C) is removed by filtration or centrifugation. It consists mainly of DL-β-hydroxyphenylglycine hydrobromide as judged by optical rotation. The separated solution containing the hydrobromide salt of D-p-hydroxyphenyl glycine is adjusted with alkali, preferably ammonia water, to pH 4-6, preferably 5.5-5.7. The crystalline free amino acid thus formed or obtained by concentration is separated by filtration or centrifugation. The D-p-hydroxyphenylglycine thus obtained is of approx. 99% purity as determined by optical rotation and thin layer chromatographic examination.

Hvis der ved fremgangsmåden anvendes en blanding af p-hydroxy-phenylglycin-alkylestere, hydrolyseres estergruppen med van-10 dig hydrogenbromidsyre ved en temperatur på fra omkring 100 til omkring 115°C. Hydrolysen er i det væsentlige fuldført på omkring 3 timer. De resulterende hydrobromidsalte af DL-p-hydroxyphenylglycin og D-p-hydroxyphenylglycin adskilles som beskrevet ovenfor. Der kan anvendes enhver alkylester, hvis 15 alkyldele indeholder 1-10 carbonatomer. Methylesterne af p-hy-droxyphenylglycinerne foretrækkes (fremstillet ved den metode, som er beskrevet i beskrivelsen til belgisk patent nr. 795 874).If the process uses a mixture of p-hydroxy-phenylglycine alkyl esters, the ester group is hydrolyzed with anhydrous hydrobromic acid at a temperature of from about 100 to about 115 ° C. The hydrolysis is essentially complete in about 3 hours. The resulting hydrobromide salts of DL-β-hydroxyphenylglycine and D-β-hydroxyphenylglycine are separated as described above. Any alkyl ester whose 15 alkyl moieties contain 1-10 carbon atoms can be used. The methyl esters of the p-hydroxyphenyl glycines are preferred (prepared by the method disclosed in the specification of Belgian Patent No. 795 874).

Det er selvfølgelig også muligt at adskille D-p-hydroxyphenylglycin fra blandinger af D- og DL-p-hydroxyphenylglycin og 20 alkylesterne deraf ved fremgangsmåden ifølge opfindelsen.Of course, it is also possible to separate D-p-hydroxyphenylglycine from mixtures of D- and DL-p-hydroxyphenylglycine and the alkyl esters thereof by the process of the invention.

EKSEMPEL 1EXAMPLE 1

En blanding (10 g) indeholdende varierende mængder D- og DL-p-hydroxyphenylglycin (Houben-Weyl 8, 279-284, 1952) og 48 % vandig hydrogenbromidsyre (26,6 ml) blev opvarmet til 100-110°C, 25 indtil der dannedes en opløsning. Den fik derpå lov at afkøles til 20-25°C. Det dannede krystallinske produkt blev fjernet ved filtrering og fandtes at være 90-96 % rent DL-p-hydroxy-phenylglycinhydrobromid som bedømt ved optisk drejning. Det fraskilte filtrat blev behandlet med ammoniakvand til pH 5,5-30 5,7. Det således dannede krystallinske produkt blev isoleret ved filtrering og vasket med methanol. Undersøgelse af dette ved optisk drejning og tyndtlagschromatografi viste, at det var D-p-hydroxyphenylglycin med 98,7-99,3 % optisk og kemisk renhed. Disse resultater er sammenfattet i tabel I.A mixture (10 g) containing varying amounts of D- and DL-β-hydroxyphenylglycine (Houben-Weyl 8, 279-284, 1952) and 48% aqueous hydrobromic acid (26.6 ml) was heated to 100-110 ° C. until a solution is formed. It was then allowed to cool to 20-25 ° C. The crystalline product formed was removed by filtration and found to be 90-96% pure DL-β-hydroxy-phenylglycine hydrobromide as judged by optical rotation. The separated filtrate was treated with ammonia water to pH 5.5-30 5.7. The crystalline product thus formed was isolated by filtration and washed with methanol. Examination of this by optical rotation and thin layer chromatography revealed that it was D-p-hydroxyphenylglycine with 98.7-99.3% optical and chemical purity. These results are summarized in Table I.

4 --- o 146801 o «Η ITV o o o4 --- o 146801 o «Η ITV o o o

cvip Η ·4 Xcvip Η · 4 X

i—i Hil S I C'-i-i Hil S I C'-

0 i_i VO0 i_i VO

43 . ... . H43. .... H

H 0 ^ ,,H

cd p is Xcd p is X

01 +3 -01 +3 -

d >>P| H O CO Pd >> P | H O CO P

Η p O O (Ti HΗ p O O (Ti H

S d^R HH ø o P «S d ^ R HH ø o P «

P PP P

P — -.....-------------------- ·Η o ρ i £P - -.....-------------------- · Η o ρ i £

P 0 0 bO O OP 0 0 bO O O

d Ρ Ρ HOH O Pd Ρ Ρ HOH O P

^ . ø >> ir\ o to H P co Ρ H W ·· « « « O <fr^. ø >> ir \ o to H P co Ρ H W ·· «« «O <fr

0 I p H -4 IN M P C\J0 I p H -4 IN M P C \ J

B fflhlffl TJ . .B fflhlffl TJ. .

ω HQiu > Xω HQiu> X

P PP P

0 - 0 <D0 - 0 <D.

d X d PØ -Pi-i ra ø >· P ø In d -H p N IC\ fn tQ *>, P ra 0 pp"Jg. - *> - I tt! Øld X d PØ -Pi-i ra ø> · P ø In d -H p N IC \ fn tQ *>, P ra 0 pp "Jg. - *> - I tt! beer

> ft cd oo cn σ> pi HP> ft cd oo cn σ> pi HP

OP CTNCTiCTv P op d P raON CTNCTiCTv P on d P ra

•H 0--CD P -Η P• H 0 - CD P -Η P

OP«· Ρ Ρ POP «· Ρ Ρ P

> p H CD O CD Si h >·. ii 1-1!b &t p o O d b(d Η d '— o ί d Si N d H o o o *rl *r! ffi Ή> p H CD O CD Si h> ·. ii 1-1! b & t p o O d b (d Η d '- o ί d Si N d H o o o * rl * r! ffi Ή

d m o in co co Sd m o in co co S

ø c\ipd in in in · cdcd ø p I—I H H H dd Hd p S S III b£ bo cd bo ^ '-j h æ æ o æø c \ ipd in in in · cdcd ø p I — I H H H dd Hd p S S III b £ bo cd bo ^ '-j h æ æ o æ

P CDP CD

d Pd P

>· P Η Ό ·· 11 II> · P Η Ό ·· 11 II

p In cdl « « Pp In cdl «« P

h i p in 4 co æ cd cdh i p in 4 co æ cd cd

P d^. IN VO CM b0 P PP d ^. IN VO CM b0 P P

P ! p ti -p -p Η P ’H >> >>P! p ti -p -p Η P 'H >> >>

ffl p--- s P Pffl p --- s P P

<U p S d d E-t cd ω P d d<U p S d d E-t cd ω P d d

ρ ρ ø Sρ ρ ø S

<H ØP Ιΰ O |C| S "SR "SR<H ØP Ιΰ O | C | S "SR" SR

Η iNbO IN 00 <1- OΗ iNbO IN 00 <1- O

d o ra « « « fq cd| pid o ra «« «fq cd | PI

•H ra i ίο <t H• H ra i ίο <t H

o Η Po Η P

> ___> ___

bC HbC H

H 0H 0

> P O O O> P O O O

d O &0 Η Η Hd O & 0 Η Η H

0 ^ P___ P--0 ^ P___ P--

> <D> <D

* P* P

0 |N0 | N

p h ra o m o d ø i bo --- >· ra ρ η cm inp h ra o m o d ø i bo ---> · ra ρ η cm in

P P PP P P

1 $ p P--1 $ p P--

I HI H

η η ©η η ©

Eπ PEπ P

q_i In ø ra O in o 1 βΟ *» *1 Λ d Q cn in m o •ri " ————.q_i In ø ra O in o 1 βΟ * »* 1 Λ d Q cn in m o • ri" ————.

PP

0 bO0 bO

P OP O

ø ra ·ø ra ·

P P PP P P

ø od h cm m w Lfe__._ 146801 5 EKSEMPEL 2ø od h cm m w Lfe __._ 146801 EXAMPLE 2

En blanding (10 g) indeholdende varierende mængder D- og DL-p-hydroxyphenylglycin-methylestere (belgisk patentskrift nr.A mixture (10 g) containing varying amounts of D and DL-β-hydroxyphenylglycine methyl esters (Belgian Pat.

795 874) og 48 % vandig hydrogenbromidsyre (26,5 nol) blev op-5 varmet til 110-115°C i omkring 3 timer. Reaktionsblandingen blev afkølet til 20-25°C og derpå filtreret. Det opnåede faste stof fandtes at være DL-p-hydroxyphenylglycin med 70-87 % renhed som bestemt ved optisk drejning. Filtratets pH-værdi blev indstillet til pH 5,5-5,7 med ammoniakvand, og det resulterende 10 krystallinske D-p-hydroxyphenylglycin blev udvundet ved filtrering. Bestemmelsen af optisk drejning og tyndtlagschroma-tografi på produktet viste, at det var af 96,8-98 % optisk og kemisk renhed. Disse resultater er sammenfattet i tabel II.795 874) and 48% aqueous hydrobromic acid (26.5 nol) were heated to 110-115 ° C for about 3 hours. The reaction mixture was cooled to 20-25 ° C and then filtered. The solid obtained was found to be DL-β-hydroxyphenylglycine with 70-87% purity as determined by optical rotation. The pH of the filtrate was adjusted to pH 5.5-5.7 with ammonia water and the resulting 10 crystalline D-p-hydroxyphenylglycine was recovered by filtration. The determination of optical rotation and thin layer chromatography on the product showed that it was of 96.8-98% optical and chemical purity. These results are summarized in Table II.

6 - · --- 1468016 - · --- 146801

(D(D

u ø pu ø p

CQCQ

ω _ω _

H OH O

t>i IA ot> i IA o

il (MP C\J 00 Η Hil (MP C \ J 00 Η H

+5 1—' CM Η ΙΆ ø 8iii !*! 8 b w+5 1— 'CM Η ΙΆ ø 8iii! *! 8 b w

W pq HW pq H

© ΪΓ! CO© ΪΓ! CO

U *--HU * - H

ω ωω ω

•d k ω X• d k ω X

j>, -P o <H ω P in N O +3j>, -P o <H ω P in N O +3

Cd I >>P| > Η HCd I >> P | > Η H

ρ P vo [>- oo .. cd ø P d'sR o cn cn X ra ω p H *d „ t» -η ω h--S <t;ρ P vo [> - oo .. cd ø P d'sR o cn cn X ra ω p H * d „t» -η ω h - S <t;

o -P HO- O CMo -P HO- O CM

U <1> 00 P ?hU <1> 00 P? H

*d Sh VO m H rlH .0 X* d Sh VO m H rlH .0 X

o <f m is o <1 rri bO K ^ £h Sh O Η A VO Ό ωo <f m is o <1 rri bO K ^ £ h Sh O Η A VO Ό ω

>d οι ω ?η ί> P> d οι ω? η ί> P

0 h k ω P 01 >__>P 0) vi οι -p i0 h k ω P 01> __> P 0) vi οι -p i

dø p tJ i ø ω Pdie p tJ i ø ω P

•η -p ω ω in π ffl Pi^R• η -p ω ω in π ffl Pi ^ R

o p ·η p ρω >> >. N CO VO P Hf η ρ ρω cn cn σ\ ω p oko p · η p ρω >>>. N CO VO P Hf η ρ ρω cn cn σ \ ω p ok

tio rci O 14 UU ω Stio rci O 14 UU ω S

«—| J3 ω 5! ·Η <H«- | J3 ω 5! · Η <H

>, ^--Hl·) -d si Od ρ ΰ 0 IP DS «Η p C\l P LP CO -et ·Η ·Η ffi Η p 1—1 lf\ ΙΛ ΙΛ !> Sri H >, 0 8 Η Η Η Φ0 Cd>, ^ - Hl ·) -d si Od ρ ΰ 0 IP DS «Η p C \ l P LP CO -et · Η · Η ffi Η p 1—1 lf \ ΙΛ ΙΛ!> Sri H>, 0 8 C Η Η Φ0 Cd

R U —1 III P -d HR U —1 III P -d H

ρ o >» bi ω cd pρ o> »bi ω cd p

p p oi--ss P bOp p oi - ss P bO

pOTd lø c\j j8 J8 o ffi c t» ρ p _ - as Ht> eh p p cn <r cn 1 >)(ij| in in 4pOTd sol c \ j j8 J8 o fi c t »ρ p _ - if Ht> eh p p cn <r cn 1>) (ij | in in 4

p4 p ·· II IIp4 p ·· II II

i P^Rin P ^ R

p p ø ø ωp p ø ø ω

S ___. bO P -PS ___. bO P -P

- s f f 0 -p -H >>- s f f 0 -p -H >>

ω Cj P Pω Cj P P

iU 0 0 N ppp ø co n ni u d diU 0 0 N ppp ø co n ni u d d

cj j—| ·» ·» £Rcj j— | · »·» £ R

•H O&O-d-rACM s "SR oR• H O & O-d-rACM s „SR oR

o 01 0 H ffl S| Pi rri - -o 01 0 H ffl S | Pi rri - -

bObO

i—I Hi — I H

{>> 0{>> 0

S P O O OS P O O O

0 O tsD Η Η H0 O tsD Η Η H

P Eri P__.P Eri P__.

£ H h 0 0 0 k ø οι p H in o dS S M - - >,>- sø w in ρω ep i ω£ H h 0 0 0 k ø οι p H in o dS S M - ->,> - sun w in ρω ep i ω

Id H PId H P

Ρ·Η -Η PΡ · Η -Η P

1 S Eri___k P o1 S Eri___k P o

U PU P

<hp ω cd S Ρ Λ _ ø ω m in o d bc ω - - o o i bo t>- in<hp ω cd S Ρ Λ _ ø ω m in o d bc ω - - o o i bo t> - in

H fj PH fj P

p P__ ø !> PP b0p P__ ø!> PP b0

0 S0 S

pd cq .pd cq.

0 0 Sr k ca S od Η ni m0 0 Sr k ca S od Η ni m

PP

DK594175A 1975-01-09 1975-12-30 PROCEDURE FOR SEPARATING D-P-HYDROXYPHENYLGYLINE FROM A MIXTURE OF D- AND DL-P-HYDROXYPHENYLGYLIN OR ITS ALKYL ESTERS OR MIXTURES THEREOF DK146801C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53971775A 1975-01-09 1975-01-09
US53971775 1975-01-09

Publications (3)

Publication Number Publication Date
DK594175A DK594175A (en) 1976-07-10
DK146801B true DK146801B (en) 1984-01-09
DK146801C DK146801C (en) 1984-06-18

Family

ID=24152365

Family Applications (1)

Application Number Title Priority Date Filing Date
DK594175A DK146801C (en) 1975-01-09 1975-12-30 PROCEDURE FOR SEPARATING D-P-HYDROXYPHENYLGYLINE FROM A MIXTURE OF D- AND DL-P-HYDROXYPHENYLGYLIN OR ITS ALKYL ESTERS OR MIXTURES THEREOF

Country Status (13)

Country Link
JP (1) JPS5191228A (en)
AR (1) AR205293A1 (en)
BE (1) BE837214A (en)
CA (1) CA1033760A (en)
DK (1) DK146801C (en)
ES (1) ES444002A1 (en)
FR (1) FR2297208A1 (en)
GB (1) GB1476110A (en)
IE (1) IE41879B1 (en)
LU (1) LU74131A1 (en)
MX (1) MX3598E (en)
NL (1) NL7514992A (en)
SE (1) SE7600016L (en)

Also Published As

Publication number Publication date
DE2552932B2 (en) 1977-07-07
LU74131A1 (en) 1976-11-11
DK594175A (en) 1976-07-10
SE7600016L (en) 1976-07-12
NL7514992A (en) 1976-07-13
DK146801C (en) 1984-06-18
DE2552932A1 (en) 1976-07-15
ES444002A1 (en) 1977-04-16
IE41879L (en) 1976-07-09
AU8791775A (en) 1977-07-07
GB1476110A (en) 1977-06-10
BE837214A (en) 1976-06-30
JPS5191228A (en) 1976-08-10
CA1033760A (en) 1978-06-27
MX3598E (en) 1981-03-25
AR205293A1 (en) 1976-04-21
IE41879B1 (en) 1980-04-09
FR2297208B1 (en) 1978-01-27
FR2297208A1 (en) 1976-08-06
JPS5636184B2 (en) 1981-08-22

Similar Documents

Publication Publication Date Title
TWI847144B (en) Synthesis of omecamtiv mecarbil
JPH03246253A (en) Separated medium
JP2023062038A (en) Method for producing gadobutrol
ES2930948T3 (en) Method for producing calcobutrol
DK146801B (en) PROCEDURE FOR SEPARATING D-P-HYDROXYPHENYLGYLINE FROM A MIXTURE OF D- AND DL-P-HYDROXYPHENYLGYLIN OR ITS ALKYL ESTERS OR MIXTURES THEREOF
JPH1087683A (en) Production of mixed glucosamine salt
US3574740A (en) Method of preparing methane sulfonamide and its derivatives
JP4564375B2 (en) Method for producing theanine
JP2023508071A (en) Method for synthesizing melphalan
JPS611695A (en) Manufacture of n-phosphonomethylglycin
JP4405675B2 (en) Method for crystallizing maleate of N- (1 (S) -ethoxycarbonyl-3-phenylpropyl) -L-alanyl-L-proline
JP3723584B2 (en) Preparation of 4-hydroxy-2,3,5-trifluorobenzoic acid
AU2017378044B2 (en) Method of preparing benzyl 4-amino-3-chloro-5-fluoro-6-(4-chloro-2-fluoro-3-methoxyphenyl)picolinate
JP2907520B2 (en) Method for producing surfactant
KR970002908B1 (en) Preparation process of alpha-l-aspartyl-l-phenyl alanine methylester
ES2261508T3 (en) PROCEDURE FOR THE PRODUCTION OF DISODIOUS SALT OF PHENYLENE-BIS-BENCIMIDAZOL-TETRASULFONIC ACID.
JPS59110656A (en) Optical resolution of 1-phenyl-2-(p-tolyl)ethylamine
JPS60146854A (en) Manufacture of nitrilotriacetate
JPS61172846A (en) Method of optical resolution of (+-)-2-chloroprorionic acid
JPS5846064A (en) Resolution of racemic compound s-(carboxymethyl)-(rs)-cysteine
JP4774192B2 (en) Process for producing crystals of zonisamide free of 1,2-dichloroethane and high-purity crystals of zonisamide
SU475345A1 (en) The method of obtaining chlorinated trisodium phosphate
SU580841A3 (en) Method of preparing (n-phosphonometnyl) glycine
JPS64393B2 (en)
JPS5838429B2 (en) Method for purifying N-benzyloxycarbonyl aspartic acid

Legal Events

Date Code Title Description
PBP Patent lapsed